Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol for prevention of atrial fibrillation after off-pump CABG
ChiCTR2000036275Phase 4Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Esmolol group with Placebo (normal saline) group (2 arms). Primary endpoint: Postoperative atrial fibrillation. Planned start Apr 2021; status: not yet recruiting.
02
Drugs
esmolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR2000036275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036275.